Pharmaceutical Executive March 12, 2025
EVERSANA’s chief digital officer discusses recent developments in the pharma industry that are impacting its relationship with patients and new technology.
Direct-to-patient (DTP) models are being utilized more and more in recent years. While this provides pharma companies with new opportunities to reach patient populations, it also creates new complications that they need to find solutions for. Scott Snyder, chief digital officer at EVERSANA, spoke with Pharmaceutical Executive about these types of models and the solutions that companies are employing.
Pharmaceutical Executive: Have direct to patient models taken off in the pharma industry as many have thought over the past year following the success of brands like Lilly?
Scott Snyder: DTP models have been in the news a lot the past...
Today's Sponsors
Today's Sponsor